Director’s Reports
Shareholding Status
Price Sensitive Information
This is for your kind information that the Board of Directors of Central Pharmaceuticals Ltd. In its meeting held on Monday 04 November, 2024 at 3:30 P.M. at the Corporate Head Office of the Company , approved the audited financial statements for the year ended 30 June, 2024. In the said board meeting following price sensitive decisions were taken:
| Proposed Dividend | : | The Board of Directors Declared No Dividend for the year ended 30 June, 2024 subject to approval of the shareholders in the 44th AGM of the company. |
| Date and time of the 44th AGM | : | Monday , 30th December, 2024 at 11:30 A.M. |
| Venue of the 44th AGM | : | Hall Patio , Gulshan Club Limited. House # Nwj/2/A, Bir uttom sultan mahmud road ,Gulshan-02, Dhaka-1212. |
| Record date for 44th AGM | : | Wednesday, 27th November, 2024 the shareholders , whose names would appear as share holders in the register of Members at the close of the business on the Record Date, shall be entitled to attend the hybrid meeting. |
The performance highlights are as follows :
| Particulars | June 30, 2024 (In BDT) | June 30, 2023 (In BDT) |
| Net Profit | (4,24,77,105) | (4,39,57,312) |
| Earnings Per Share | (0.35) | (0.37) |
| Net Asset Value Per share | 7.06 | 5.59 |
| Net Operating Cash Flow Per Share | 0.02 | (0.00) |